Platelet Rich Plasma (PRP) One-Shot Injection For Supraspinatus Tendinosis
Completed
- Conditions
- Supraspinatus Tendinitis
- Interventions
- Procedure: one-shot PRP injection
- Registration Number
- NCT04851951
- Brief Summary
It was conducted a prospective study with a series of 50 patients treated with PRP one-shot injection in patient affected by Supraspinatus Tendinosis. One independent observer performed clinical and functional evaluations at T0 (recruitment), T1 (one month after the injection), T2 (three months after the last injection) and T3 (six months after the last injection).
Constant Score, The Disabilites of the Arm,Shoulder and Hand Score (DASH) And Visual Analogue Scale (VAS) were administered at each evaluation.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 48
Inclusion Criteria
- Age > 18 years old;
- Supraspinatus tendinosis detected by MRI.
Exclusion Criteria
- Supraspinatus rupture;
- Previous shoulder surgery;
- Rotator cuff tears secondary to fracture;
- Hemoglobin <7 g/dL or Platelets < 30,000 microL;
- Active infection;
- Pregnant patients;
- Patients with hematologic and oncologic diseases.
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Arm && Interventions
Group Intervention Description patients treated by one-shot PRP injection one-shot PRP injection -
- Primary Outcome Measures
Name Time Method Change in Visual Analogic Scale Day 0; Month 1; Month 3; Month 6 (after the injection) The shoulder pain was quantified using the Visual Analogic Scale ranging from 0 (no pain) to 10 (worst imaginable pain).
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
AOUC Policlinico di Bari - UOC Ortopedia e Traumatologia
🇮🇹Bari, Italy